Filed: 8/7/2026ACC: 0001104659-26-092709
📋 What this filing means
REGENERON PHARMACEUTICALS, INC. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $177.22M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$177.22M
Total AUM (reported)
7.93M
Total Shares
Allocation by class
COMMON STOCK$177.22M100.0%
Portfolio Concentration
Top 3$177.22M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.93M
Sole
Full voting authority
7.93M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
Parabilis Medicines, Inc.
SOLEShares4.17M
TypeSH
Market value$114.04M
64.35%
Sole
4.17M
Shared
0.00
None
0.00
Intellia Therapeutics, Inc.
SOLEShares3.70M
TypeSH
Market value$62.65M
35.35%
Sole
3.70M
Shared
0.00
None
0.00
Adicet Bio, Inc.
SOLEShares60.51K
TypeSH
Market value$522.8K
0.30%
Sole
60.51K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Parabilis Medicines, Inc.SOLE | Common Stock | 4.17M | SH | $114.04M 64.35% | 4.17M | 0.00 | 0.00 |
Intellia Therapeutics, Inc.SOLE | Common Stock | 3.70M | SH | $62.65M 35.35% | 3.70M | 0.00 | 0.00 |
Adicet Bio, Inc.SOLE | Common Stock | 60.51K | SH | $522.8K 0.30% | 60.51K | 0.00 | 0.00 |